Abortion pill mifepristone: An explainer and research roundup about its history, safety and future
This piece aims to help inform the narrative on medication abortion with scientific evidence, especially since with abortion-related measures on the ballot in several states, journalistic coverage of the topic has never been more crucial. Medication abortion is also known as abortion with pills or medical abortion.
Legal Status and Supreme Court Rulings
The legal future of mifepristone had hung in the balance for several months before recent judicial clarity. On June 13, the Supreme Court justices in a unanimous decision preserved access to mifepristone, a medication that’s used for the safe termination of early pregnancy, writing that “federal courts are the wrong forum for addressing the plaintiffs’ concerns about FDA’s actions.”
Prior to this, the following legal timeline shaped the availability of the medication:
- In August 2023, the 5th U.S. Circuit Court of Appeals ruled that mifepristone should not be prescribed past the seventh week of pregnancy, prescribed via telemedicine, or shipped to patients through the mail.
- In September, the Justice Department asked the Supreme Court to consider a challenge to that ruling.
- On Dec. 13, 2023, the Supreme Court justices announced that they would take up the case on the availability of mifepristone.
- The justices heard oral arguments on March 26, 2024 before issuing the June 13 ruling.
Medical Guidelines and Safety
It’s important for journalists covering abortion to have a good understanding of medication abortion so that they can better inform their audiences about what research shows regarding its safety and effectiveness. It is endorsed by several organizations, including the American College of Obstetricians & Gynecologists and the American Medical Association.
The following table summarizes the primary usage guidelines provided by health authorities:
| Organization | Guideline/Authorization |
|---|---|
| Food and Drug Administration (FDA) | Approved for up to 10 weeks of pregnancy. |
| World Health Organization (WHO) | Authorizes use for up to 12 weeks; also notes it can be used beyond 12 weeks. |
| International Federation of Gynecology and Obstetrics | Supports use beyond 12 weeks of pregnancy. |
Research on Media Representation
A recent analysis of more than 1,100 articles, published between January 2022 and June 2023 in five major U.S. news outlets, finds that "while U.S. newspapers are treating the topic of abortion in general and medication abortion access in particular as serious policy issues, they are under-covering medication abortion considering its prevalence as the leading abortion method in the U.S., and its importance to abortion seekers."
According to the study, published in Sexuality Research and Social Policy in June 2025, the following trends were observed in media coverage:
- Politicians and lawyers were quoted more than healthcare providers.
- Less than half of the articles included basic facts on medication abortion.
- Only one in five articles included a personal story of someone seeking abortion.
Meanwhile, abortion is on the ballot in four states this year so far, with initiatives that aim to ban, restrict, or expand abortion rights.